Literature DB >> 19796605

Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.

Christian E Badr1, Johanna M Niers, Lee-Ann Tjon-Kon-Fat, David P Noske, Thomas Wurdinger, Bakhos A Tannous.   

Abstract

Nuclear factor kappaB (NF-kappaB) is a transcription factor that plays a major role in many human disorders, including immune diseases and cancer. We designed a reporter system based on NF-kappaB responsive promoter elements driving expression of the secreted Gaussia princeps luciferase (Gluc). We show that this bioluminescent reporter is a highly sensitive tool for noninvasive monitoring of the kinetics of NF-kappaB activation and inhibition over time, both in conditioned medium of cultured cells and in the blood and urine of animals. NF-kappaB activation was successfully monitored in real time in endothelial cells in response to tumor angiogenic signaling, as well as in monocytes in response to inflammation. Further, we demonstrated dual blood monitoring of both NF-kappaB activation during tumor development as correlated to tumor formation using the NF-kappaB Gluc reporter, as well as the secreted alkaline phosphatase reporter. This NF-kappaB reporter system provides a powerful tool for monitoring NF-kappaB activity in real time in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796605      PMCID: PMC2856067     

Source DB:  PubMed          Journal:  Mol Imaging        ISSN: 1535-3508            Impact factor:   4.488


  60 in total

1.  Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.

Authors:  Zhenfa Zhang; Jianqun Ma; Ni Li; Nan Sun; Changli Wang
Journal:  Ann Thorac Surg       Date:  2006-07       Impact factor: 4.330

Review 2.  Shared principles in NF-kappaB signaling.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

3.  A secreted luciferase for ex vivo monitoring of in vivo processes.

Authors:  Thomas Wurdinger; Christian Badr; Lisa Pike; Ruben de Kleine; Ralph Weissleder; Xandra O Breakefield; Bakhos A Tannous
Journal:  Nat Methods       Date:  2008-01-20       Impact factor: 28.547

4.  Transfection with anti-p65 intrabody suppresses invasion and angiogenesis in glioma cells by blocking nuclear factor-kappaB transcriptional activity.

Authors:  Liang Li; Christopher S Gondi; Dzung H Dinh; William C Olivero; Meena Gujrati; Jasti S Rao
Journal:  Clin Cancer Res       Date:  2007-04-01       Impact factor: 12.531

5.  NF-kappaB controls growth of glioblastomas/astrocytomas.

Authors:  Denise Smith; Takeshi Shimamura; Stephanie Barbera; Bruce E Bejcek
Journal:  Mol Cell Biochem       Date:  2007-09-09       Impact factor: 3.396

6.  Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy.

Authors:  Robert U Svensson; J Matthew Barnes; Oskar W Rokhlin; Michael B Cohen; Michael D Henry
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

7.  Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease.

Authors:  Anamitra Ghosh; Avik Roy; Xiaojuan Liu; Jeffrey H Kordower; Elliott J Mufson; Dean M Hartley; Sankar Ghosh; R Lee Mosley; Howard E Gendelman; Kalipada Pahan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-13       Impact factor: 11.205

8.  Expression of nuclear factor-kappaB in human astrocytomas: relation to pI kappa Ba, vascular endothelial growth factor, Cox-2, microvascular characteristics, and survival.

Authors:  Penelope Korkolopoulou; Georgia Levidou; Angelica A Saetta; Elias El-Habr; Christos Eftichiadis; Polychronis Demenagas; Irene Thymara; Konstantinos Xiromeritis; Efstathios Boviatsis; Euphemia Thomas-Tsagli; Ioannis Panayotidis; Efstratios Patsouris
Journal:  Hum Pathol       Date:  2008-05-20       Impact factor: 3.466

Review 9.  NF-kappaB as a potential molecular target for cancer therapy.

Authors:  Chae Hyeong Lee; Yong-Tark Jeon; Su-Hyeong Kim; Yong-Sang Song
Journal:  Biofactors       Date:  2007       Impact factor: 6.113

10.  A highly sensitive assay for monitoring the secretory pathway and ER stress.

Authors:  Christian E Badr; Jeffrey W Hewett; Xandra O Breakefield; Bakhos A Tannous
Journal:  PLoS One       Date:  2007-06-27       Impact factor: 3.240

View more
  41 in total

1.  Enhanced Gaussia luciferase blood assay for monitoring of in vivo biological processes.

Authors:  M Sarah S Bovenberg; M Hannah Degeling; Bakhos A Tannous
Journal:  Anal Chem       Date:  2011-12-27       Impact factor: 6.986

2.  NFκB and HIF display synergistic behaviour during hypoxic inflammation.

Authors:  Ulrike Bruning; Susan F Fitzpatrick; Till Frank; Marc Birtwistle; Cormac T Taylor; Alex Cheong
Journal:  Cell Mol Life Sci       Date:  2011-11-09       Impact factor: 9.261

3.  Functional drug screening assay reveals potential glioma therapeutics.

Authors:  Christian E Badr; Thomas Wurdinger; Bakhos A Tannous
Journal:  Assay Drug Dev Technol       Date:  2010-12-27       Impact factor: 1.738

4.  A Synthetic Gene Circuit for Self-Regulating Delivery of Biologic Drugs in Engineered Tissues.

Authors:  Lara Pferdehirt; Alison K Ross; Jonathan M Brunger; Farshid Guilak
Journal:  Tissue Eng Part A       Date:  2019-05       Impact factor: 3.845

5.  Lanatoside C sensitizes glioblastoma cells to tumor necrosis factor-related apoptosis-inducing ligand and induces an alternative cell death pathway.

Authors:  Christian E Badr; Thomas Wurdinger; Jonas Nilsson; Johanna M Niers; Michael Whalen; Alexei Degterev; Bakhos A Tannous
Journal:  Neuro Oncol       Date:  2011-07-13       Impact factor: 12.300

6.  X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.

Authors:  Christine A Vaine; David Shin; Christina Liu; William T Hendriks; Jyotsna Dhakal; Kyle Shin; Nutan Sharma; D Cristopher Bragg
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

7.  Dissecting inherent intratumor heterogeneity in patient-derived glioblastoma culture models.

Authors:  Jian Teng; Cintia C da Hora; Rami S Kantar; Ichiro Nakano; Hiroaki Wakimoto; Tracy T Batchelor; E Antonio Chiocca; Christian E Badr; Bakhos A Tannous
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

8.  Quercetin and its metabolites protect hepatocytes against ethanol-induced oxidative stress by activation of Nrf2 and AP-1.

Authors:  Yoo-Jung Lee; Song-Yi Beak; Inho Choi; Jung-Suk Sung
Journal:  Food Sci Biotechnol       Date:  2017-12-12       Impact factor: 2.391

Review 9.  Secreted blood reporters: insights and applications.

Authors:  Bakhos A Tannous; Jian Teng
Journal:  Biotechnol Adv       Date:  2011-09-08       Impact factor: 14.227

10.  Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.

Authors:  Adrienn Volak; Stanley G LeRoy; Jeya Shree Natasan; David J Park; Pike See Cheah; Andreas Maus; Zachary Fitzpatrick; Eloise Hudry; Kelsey Pinkham; Sheetal Gandhi; Bradley T Hyman; Dakai Mu; Dwijit GuhaSarkar; Anat O Stemmer-Rachamimov; Miguel Sena-Esteves; Christian E Badr; Casey A Maguire
Journal:  J Neurooncol       Date:  2018-05-16       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.